Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELIGHT Trial: Tributyrin to Improve Gut-Brain Health and Delirium in Colorectal Surgery
ChiCTR2600127158Phase 2Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative delirium (POD) and colorectal cancer (CRC) comparing Tributyrin syrup with Placebo syrup (2 arms). Primary endpoint: Tolerability and adherence to preoperative oral butyrate glyceride regimen. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
tributyrin
03
Conditions
postoperative delirium (POD)colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2600127158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127158.